Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition: Nephrotic Syndrome Interventions: Drug: Dapagliflozin and Standard therapy (ACEI or ARB).; Drug: Standard Therapy (ACEI or ARB). Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Conditions: Diabetes Mellitus; Hypertension Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
Condition: Chronic Kidney Diseases Intervention: Other: Dapagliflozin indication on chronic renal failure patients Sponsor: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
Condition: Chronic Kidney Diseases Intervention: Drug: impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients Sponsor: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients
Condition: STEMI Intervention: Drug: Dapagliflozin Sponsor: Mohamed Nabil Elkholy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2023 Category: Research Source Type: clinical trials
